| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.38M | $170.65M | - | |
| CEO | 324.9K | $40.10M | - | |
| CFO | 99.2K | $12.25M | - | |
| Other | 86.8K | $10.72M | -5,500 | |
| Other | 83.4K | $10.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Noci Darlene | Chief Development Officer | Sale+OE | 4,000 | $83.07 | $332,288.05 | -1.6% | +19.9% | - | |
| Sep 15, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $79.08 | $2,135,055.30 | -3.4% | +32.3% | - | |
| Sep 10, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sale+OE | 3,725 | $78.83 | $293,641.75 | -5.3% | +33.9% | - | |
| Aug 25, 2025 | Noci Darlene | Chief Development Officer | Sale+OE | 4,000 | $74.62 | $298,488.74 | -2.7% | +47.9% | - | |
| Aug 15, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $75.42 | $2,036,325.40 | -3.5% | +24.5% | - | |
| Aug 7, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sale+OE | 5,500 | $74.85 | $411,675.00 | -8.3% | +27.6% | - | |
| Jul 30, 2025 | Noci Darlene | Chief Development Officer | Sale+OE | 4,000 | $80.36 | $321,440.00 | -7.7% | +27.3% | - | |
| Jul 16, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 20,000 | $84.67 | $1,693,496.10 | -6.0% | -0.9% | - | |
| Jul 15, 2025 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $82.27 | $2,221,419.35 | -2.6% | +8.2% | - | |
| Jul 10, 2025 | Pelish Henry E.61 | Chief Scientific Officer | Sale+OE | 7,645 | $80.31 | $613,985.80 | -3.0% | +3.4% | - |